Description

This fund's investment strategy involves allocating capital to various financial instruments, carefully selected by its adviser, with the aim of achieving daily returns that align with its stated objectives. It seeks to track a specific index that measures the performance of select companies within the U.S. biotechnology sector of the equity market. Notably, the fund employs a concentrated investment approach, meaning it is not diversified.